Citation: Ph. Vlasses et Cj. Adarmes, UNDERUTILIZATION OF ACCEPTED THERAPIES - AN OVERLOOKED COMPONENT OF PHARMACEUTICAL CARE, The Annals of pharmacotherapy, 31(12), 1997, pp. 1537-1538
Authors:
ALBERS GW
BITTAR N
YOUNG L
HATTEMER CR
GANDHI AJ
KEMP SM
HALL EA
MORTON DJ
YIM J
VLASSES PH
Citation: Gw. Albers et al., CLINICAL CHARACTERISTICS AND MANAGEMENT OF ACUTE STROKE IN PATIENTS WITH ATRIAL-FIBRILLATION ADMITTED TO US UNIVERSITY HOSPITALS, Neurology, 48(6), 1997, pp. 1598-1604
Citation: Jm. Yim et al., ANTICOAGULANT-THERAPY MONITORING WITH INTERNATIONAL NORMALIZED RATIO AT US ACADEMIC HEALTH CENTERS, The Annals of pharmacotherapy, 30(12), 1996, pp. 1390-1395
Authors:
ALBERS GW
YIM JM
BELEW KM
BITTAR N
HATTEMER CR
PHILLIPS BG
KEMP S
HALL EA
MORTON DJ
VLASSES PH
Citation: Gw. Albers et al., STATUS OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL-FIBRILLATION IN UNIVERSITY HOSPITALS, Archives of internal medicine, 156(20), 1996, pp. 2311-2316
Authors:
PHILLIPS BG
YIM JM
BROWN EJ
BITTAR N
HOON TJ
CELESTIN C
VLASSES PH
BAUMAN JL
Citation: Bg. Phillips et al., PHARMACOLOGICAL PROFILE OF SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION AT UNITED-STATES ACADEMIC HOSPITALS, The American heart journal, 131(5), 1996, pp. 872-878
Authors:
YIM JM
MATUSZEWSKI KA
VERMEULEN LC
RATKO TA
BURNETT DA
VLASSES PH
Citation: Jm. Yim et al., SURVEILLANCE OF COLONY-STIMULATING FACTOR USE IN US ACADEMIC HEALTH CENTERS, The Annals of pharmacotherapy, 29(5), 1995, pp. 475-481
Citation: Ka. Matuszewski et Ph. Vlasses, SURVEY RESULTS FROM ACADEMIC HEALTH-CENTER INTENSIVE-CARE UNITS - CONSIDERATIONS FOR DEPARTMENTS OF PHARMACY, Clinical therapeutics, 17(3), 1995, pp. 517-524
Authors:
YIM JM
VERMEULEN LC
ERSTAD BL
MATUSZEWSKI KA
BURNETT DA
VLASSES PH
Citation: Jm. Yim et al., ALBUMIN AND NONPROTEIN COLLOID SOLUTION USE IN US ACADEMIC HEALTH CENTERS, Archives of internal medicine, 155(22), 1995, pp. 2450-2455
Authors:
YIM JM
HOON TJ
BITTER N
BAUMAN JL
BROWN EJ
CELESTIN C
PHILLIPS BG
VLASSES PH
Citation: Jm. Yim et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR USE IN SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 75(16), 1995, pp. 1184-1186
Authors:
VERMEULEN LC
MATUSZEWSKI KA
RATKO TA
BUTLER CD
BURNETT DA
VLASSES PH
Citation: Lc. Vermeulen et al., EVALUATION OF ONDANSETRON PRESCRIBING IN US ACADEMIC MEDICAL-CENTERS, Archives of internal medicine, 154(15), 1994, pp. 1733-1740
Authors:
ZAROWITZ BJ
VLASSES PH
DUKES GE
GAL P
MILLER WA
PORTER WC
RUSH DR
SCHNEIDER P
TALBERT RL
Citation: Bj. Zarowitz et al., PHARMACOTHERAPY SPECIALTY CERTIFICATION EXAMINATION .4. 1992 RESULTS AND PROCESS MODIFICATIONS, INCLUDING RECERTIFICATION, Pharmacotherapy, 13(3), 1993, pp. 262-266
Citation: Hh. Rotmensch et al., COMPARISONS OF BETA-ADRENERGIC BLOCKING PROPERTIES OF S-TIMOLOL AND R-TIMOLOL IN HUMANS, Journal of clinical pharmacology, 33(6), 1993, pp. 544-548
Authors:
UJHELYI MR
ROBERT S
CUMMINGS DM
COLUCCI RD
SAILSTAD JM
VLASSES PH
FINDLAY JWA
ZAROWITZ BJ
Citation: Mr. Ujhelyi et al., DISPOSITION OF DIGOXIN IMMUNE FAB IN PATIENTS WITH KIDNEY FAILURE, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 388-394
Authors:
UJHELYI MR
ROBERT S
CUMMINGS DM
COLUCCI RD
GREEN PJ
SAILSTAD J
VLASSES PH
ZAROWITZ BJ
Citation: Mr. Ujhelyi et al., INFLUENCE OF DIGOXIN IMMUNE FAB THERAPY AND RENAL DYSFUNCTION ON THE DISPOSITION OF TOTAL AND FREE DIGOXIN, Annals of internal medicine, 119(4), 1993, pp. 273-277
Authors:
ROBERTS SA
DIAZ C
NOLAN PE
SALERNO DM
STAPCZYNSKI JS
ZBROZEK AS
RITZ EG
BAUMAN JL
VLASSES PH
Citation: Sa. Roberts et al., EFFECTIVENESS AND COSTS OF DIGOXIN TREATMENT FOR ATRIAL-FIBRILLATION AND FLUTTER, The American journal of cardiology, 72(7), 1993, pp. 567-573
Authors:
UJHELYI MR
GREEN PJ
CUMMINGS DM
ROBERT S
VLASSES PH
ZAROWITZ BJ
Citation: Mr. Ujhelyi et al., DETERMINATION OF FREE SERUM DIGOXIN CONCENTRATIONS IN DIGOXIN TOXIC PATIENTS AFTER ADMINISTRATION OF DIGOXIN FAB ANTIBODIES, Therapeutic drug monitoring, 14(2), 1992, pp. 147-154